会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 14. 发明授权
    • Fetal cell separation and testing
    • 胎儿细胞分离和检测
    • US4675286A
    • 1987-06-23
    • US695971
    • 1985-01-28
    • Emanuel Calenoff
    • Emanuel Calenoff
    • A61B10/00A61B10/02C12Q1/24G01N33/569G01N33/543G01N33/554G01N33/577
    • A61B10/02C12Q1/24G01N33/56966Y10T436/25375Y10T436/255
    • A method for obtaining fetal cells for diagnostic examination comprises removing detached cells from the uterine cavity and outer surface of the amnionic sac. The cells are then incubated in the presence of a separation antibody which binds preferentially to either fetal cell antigens or maternal cell antigens for a time sufficient to permit antibody-antigen binding to occur. Cells having said separation antibody bound thereto are separated for the mixture. The separation antibody can be an anitbody binding preferentially to fetal cell antigens and not significantly to maternal cell antigens or it can be an antibody binding preferentially to maternal cell antigens and not significantly to fetal cell antigens. The antibody can be bound to an insoluble support prior to the incubation, and separation can be effected by separating the insoluble support from the cell mixture following the incubation. Alternatively, the separation antibody can be fluorescent labeled, and cells conjugated with fluorescent labeled antibody can be removed using a cell sorter. The isolated fetal cells are then propagated to obtain a population sufficient for diagnostic examination.
    • 用于获得用于诊断检查的胎儿细胞的方法包括从子宫腔和羊膜囊的外表面去除分离的细胞。 然后将细胞在分离抗体存在下孵育,所述分离抗体优先结合胎儿细胞抗原或母体细胞抗原足以允许发生抗体 - 抗原结合的时间。 分离具有与之结合的分离抗体的细胞用于混合物。 分离抗体可以是优先结合胎儿细胞抗原的抗体,而不是显着地与母体细胞抗原结合,或者它可以是优先与母体细胞抗原结合的抗体,而不是显着地与胎儿细胞抗原结合。 在孵育之前,抗体可以结合到不溶性载体上,并且可以通过在孵育后从细胞混合物中分离不溶性载体来进行分离。 或者,分离抗体可以是荧光标记的,并且可以使用细胞分选机除去与荧光标记抗体缀合的细胞。 然后将分离的胎儿细胞繁殖以获得足以进行诊断检查的群体。
    • 18. 发明授权
    • DNA probe diffraction assay and reagents
    • DNA探针衍生物测定和试剂
    • US5089387A
    • 1992-02-18
    • US216691
    • 1988-07-07
    • Yuh-Geng TsayEmanuel CalenoffEric K. GustafsonRick TrebinoJohn Lee
    • Yuh-Geng TsayEmanuel CalenoffEric K. GustafsonRick TrebinoJohn Lee
    • G01N21/47C12Q1/68G01N21/77G01N33/543G02B5/18
    • G01N21/4788C12Q1/6825G01N33/54373G01N2021/757
    • The assay of the subject invention uses DNA sequences as probes in a nucleic acid hybridization diffraction assay, to detect specific DNA sequences in a sample. Diffraction assay methodologies are applied to determine the presence and amount of analyte.This invention involves a discovery in the areas of supporting surfaces for a biogrid or biograting which provide greatly reduced non-specific hybridization and binding. A preferred process of this invention involves manufacturing a biograting for use in a light diffraction assay, and comprises adhering a uniform layer of hybridizing reagent comprising a nucleotide sequence on a smooth, solid surface and exposing the surface to UV radiation through a shadow mask with a diffraction grating pattern of lines to selectively deactivate the hybridizing reagent, leaving a biological diffraction grating design of lines of active hybridizing reagent. The smooth, solid surface is preferably selected from the group consisting of polysilicon and single crystalline silicon surfaces.The diffraction hybridizing assay method of this invention for determining the presence or quantity of an analyte in an aqueous sample comprises contacting a nucleic acid sequence diffraction biogrid with the sample under proper circumstances and for a sufficient time to permit nucleic acid hybridization between a nucleic acid sequence probe and an analyte; separating the biogrid from the sample; illuminating the biogrid with light from a light source; and determining the light diffracted by the diffraction hybridization assay surface.